Disparities in Risk Reduction Therapy Recommendations for Young Women With Lobular Carcinoma In-Situ.

Bandera BC, Voci A, Nelson DW, Stern S, Barrak D, Fischer TD, DiNome ML, Goldfarb M

Open source

DOI
10.1016/j.clbc.2020.01.006
Published
2020 Aug
Container
Clinical breast cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clbc.2020.01.006,
  title = {Disparities in Risk Reduction Therapy Recommendations for Young Women With Lobular Carcinoma In-Situ.},
  author = {Bandera BC and Voci A and Nelson DW and Stern S and Barrak D and Fischer TD and DiNome ML and Goldfarb M},
  year = {2020},
  journal = {Clinical breast cancer},
  doi = {10.1016/j.clbc.2020.01.006},
  url = {https://doi.org/10.1016/j.clbc.2020.01.006}
}

RIS

TY  - JOUR
TI  - Disparities in Risk Reduction Therapy Recommendations for Young Women With Lobular Carcinoma In-Situ.
AU  - Bandera BC
AU  - Voci A
AU  - Nelson DW
AU  - Stern S
AU  - Barrak D
AU  - Fischer TD
AU  - DiNome ML
AU  - Goldfarb M
PY  - 2020
JO  - Clinical breast cancer
DO  - 10.1016/j.clbc.2020.01.006
UR  - https://doi.org/10.1016/j.clbc.2020.01.006
ER  - 

APA

BC, B., A, V., DW, N., S, S., D, B., TD, F., ML, D., & M, G. (2020). Disparities in Risk Reduction Therapy Recommendations for Young Women With Lobular Carcinoma In-Situ.. Clinical breast cancer. https://doi.org/10.1016/j.clbc.2020.01.006

Source records